Picture of Turk Ilac ve Serum Sanayi AS logo

TRILC.E Turk Ilac ve Serum Sanayi AS Share Price

0.000.00%
tr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-6.34%
3m+20.61%
6m-14.31%
1yr+31.5%
Volume Change (%)
10d/3m-22.25%
Price vs... (%)
52w High-38.95%
50d MA+10.43%
200d MA+10.82%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital18.38%
Return on Equity4.33%
Operating Margin20.95%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueTRYm199.5672.61,636.912,774.252,567.67n/an/a75.98%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+153.02-3.2n/an/a-51.15n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Turk Ilac ve Serum Sanayi AS EPS forecast chart

Profile Summary

Turk Ilac ve Serum Sanayi AS is a Turkey-based pharmaceutical company. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The company also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.

Directors

    Last Annual
    December 31st, 2024
    Last Interim
    December 31st, 2024
    Incorporated
    December 4th, 2012
    Public Since
    March 5th, 2021
    No. of Employees
    541
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    tr flag iconIstanbul Stock Exchange
    Shares in Issue
    161,805,000
    Blurred out image of a map
    Address
    Bugduz Mah. Enver Pasa Cad. No:8 Akyurt, Ankara, 06750
    Web
    https://www.turkilac.com.tr
    Phone
    +90 3128376767
    Auditors
    DENEYIM BAGIMSIZ DENETIM VE DANISMANLIK A.S.

    TRILC.E Share Price Performance

    Upcoming Events for TRILC.E

    Turk Ilac ve Serum Sanayi AS Annual Shareholders Meeting

    FAQ